How Age Reshapes Hair Biology in Men
At DiStefano, we see every day that age does not suddenly “switch on” hair loss. Instead, it magnifies biological processes that have been quietly at work for years. In men, the central driver is androgenetic alopecia, a genetic sensitivity of hair follicles to dihydrotestosterone (DHT). With age, the cumulative effect of DHT on susceptible follicles becomes more obvious, even if hormone levels themselves are not dramatically changing.
DHT is produced when the enzyme 5-alpha reductase converts testosterone into a more potent androgen. On the scalp of a genetically predisposed man, DHT binds to receptors in the hair follicle, especially in the frontal and vertex regions. Over many years, that binding slowly shortens the growth phase of the hair cycle and miniaturizes the follicle. Kische and colleagues in JAMA Dermatology showed that the prevalence of male pattern hair loss rises sharply with age, affecting at least half of men by age 50 and many more by age 70. They also showed that baldness severity is better explained by follicle sensitivity than by simple testosterone levels.
Clinically, we see this in New England men who tell us, “My hairline looked fine until my mid-30s, then things really sped up.” The reality is that miniaturization often began quietly in their 20s. Age simply gives DHT more time to work. Each successive growth cycle tends to produce a thinner, shorter hair. Eventually, the follicle may produce only soft vellus hairs that provide almost no coverage. By the time a man reaches his 40s or 50s, the accumulated cycles of miniaturization can translate into visible hair loss across the hairline and crown.
Another age-dependent factor is pattern clarity. In a man’s 20s, it is often hard to predict how far his hair loss will progress. By the 40s, the pattern is usually obvious. That is why we often recommend aggressive medical therapy early, and more strategic, pattern-based surgical planning later. Finasteride, minoxidil, low-level laser therapy, and platelet-rich plasma have their greatest impact when the follicle is still biologically active. The older a follicle becomes under DHT pressure, the harder it is to bring it back to full strength.
We also factor in systemic aging. As men age, they accumulate cardiovascular risk factors, take more medications, and experience subtle microvascular changes. All of that influences scalp blood flow and follicle nutrition. Vessels that once delivered an abundant supply of oxygen and nutrients may become less efficient. Researchers studying scalp biopsy specimens in older men have documented reduced perifollicular vascularity in advanced androgenetic alopecia, which helps explain why late-stage loss is harder to reverse.
In short, male hair aging is the visible result of three converging timelines. First, your genetics determine which follicles are vulnerable. Second, DHT interacts with those follicles over decades. Third, age brings vascular and metabolic changes that make follicles less resilient. At DiStefano, our job is to understand where you are on those three timelines and intervene with the right combination of hair restoration strategies before too many follicles cross the point of no return.
Female Hair Aging: Menopause, Hormones, and Pattern Thinning
While our patient base is predominantly male, we treat a significant number of women across New England who are distressed by age-related thinning. Their story is biologically distinct, even though some of the same hormones are involved. In women, the key inflection point is often perimenopause and menopause, when estrogen and progesterone levels decline and the relative influence of androgens increases.
Estrogen appears to provide a protective effect on the hair cycle. It helps maintain a longer growth phase and supports a more robust dermal papilla, the structure at the base of the follicle that regulates hair production. As estrogen falls in the late 40s and 50s, that protection weakens. Salam and co-authors, writing in the BMJ, highlighted hair loss as an important and under-recognized symptom of menopause, with many women reporting diffuse thinning and widening of the part line around this time.
Unlike men, women rarely develop a bare, shiny scalp in a classic pattern. Instead, they tend to experience female pattern hair loss, where density gradually decreases over the central scalp and along the part, while the frontal hairline is often preserved. Histologic studies published in Journal of the American Academy of Dermatology and Clinical, Cosmetic and Investigational Dermatology show that aging women with this pattern have the same core finding as men: progressive follicular miniaturization. However, the distribution is different, and the hormonal triggers are more complex, involving not only androgens but also changes in estrogen, progesterone, and sometimes thyroid function.
Age also increases the likelihood of concurrent conditions that contribute to shedding in women. Iron deficiency, low vitamin D, autoimmune thyroid disease, and chronic telogen effluvium are all more common in midlife and beyond. Studies in the Journal of Cosmetic Dermatology have documented improved density in women after correcting iron deficiency or Vitamin D deficiency, illustrating that “age-related hair loss” is often a combination of hormonal and nutritional factors rather than a single diagnosis.
In practice, when we evaluate an older female patient, we look carefully at three layers. First, we determine whether she has classic female pattern hair loss. Second, we screen for correctable contributors such as iron deficiency or thyroid disease. Third, we assess the impact of menopause and medications. Once we have that picture, we can build a plan that might include topical minoxidil, low-dose oral anti-androgens in appropriate candidates, PRP, and in select cases, hair transplant to reinforce the part line or frontal density.
Although this article focuses primarily on men, it is important to say clearly that aging women are not simply “supposed” to lose their hair with no options. Menopause changes the hormonal playing field, but it does not eliminate the possibility of meaningful improvement. We routinely see women in their 50s, 60s, and even 70s respond to a targeted, evidence-based approach once the underlying pattern is correctly identified.
The Biology of Follicle Aging: Miniaturization, Senescence, and Growth Cycle Slowdown
At DiStefano, we’ve learned that age-related hair loss is not one mechanism but a layered set of biological changes unfolding over decades. While DHT drives the genetically programmed miniaturization seen in male pattern hair loss, cellular aging—what scientists call follicular senescence—acts as an independent force affecting both men and women.
A healthy hair follicle cycles continuously through anagen (growth), catagen (transition), and telogen (rest). In youth, the anagen phase for scalp hair lasts years. With age, that cycle shortens. Studies published in Dermatology by Deng and colleagues describe how aging follicles exhibit stem cell exhaustion, mitochondrial decline, and accumulation of DNA damage that lead to a progressively shorter anagen phase and a disproportionately long telogen phase. This means fewer hairs are actively growing, more are resting, and density appears to fall even in the absence of active balding.
The dermal papilla, the command center of the follicle, also shrinks with age. Its reduced size translates into less signaling to the matrix cells that build the hair shaft, producing thinner strands that break more easily. Some researchers have coined the term senescent alopecia to describe this diffuse age-related thinning, which can appear in men and women independently of classic androgenetic alopecia. This explains why even men who “keep their hair” into older age may notice diminished volume or slower regrowth after shedding.
Inflammatory pathways add another layer of age pressure. Senescent cells secrete cytokines—collectively called the SASP (senescence-associated secretory phenotype)—which create a low-grade inflammatory environment around the follicle. Decades of UV exposure, oxidative stress, and environmental insults amplify this process, gradually degrading the structural integrity of hair-bearing skin.
The end result is clear: the older the follicle, the harder it becomes to reverse its decline, even if the hormonal stimulus is controlled. This is why younger patients respond more dramatically to medical therapies and why early intervention often preserves far more density than attempting to rescue heavily aged follicles. However, it also explains why many older patients still see meaningful improvements when given multi-modal treatments—such as PRP, low-level laser therapy, and judicious medical therapy—that specifically target senescent biology and microvascular decline.
In daily practice, we integrate these scientific insights by assessing both the age of the follicle and the stage of the hair loss. A young man with fresh miniaturization may respond robustly to finasteride alone. A man in his late 50s typically benefits from combining medical therapy with biologic stimulation and, if appropriate, hair transplantation to compensate for decades of follicular attrition. Our goal is to match the biology to the therapy—not simply the diagnosis.
Nutritional and Metabolic Changes With Age That Influence Hair Density
Age affects not only hormones but also the body’s ability to process, absorb, and deliver essential nutrients. Hair—being a rapid turnover tissue—suffers quickly when metabolic efficiency declines. This is especially true in older adults, who often experience subtle deficiencies that accumulate silently before manifesting as shedding or reduced density.
Iron deficiency remains one of the most important nutritional contributors to hair loss, especially in women. Although menstruation is often the dominant factor earlier in life, studies in Journal of Cosmetic Dermatology show that iron deficiency continues to be underdiagnosed in postmenopausal women and can independently produce diffuse thinning. Ferritin, the body’s iron storage protein, is frequently lower than expected even in women with normal hemoglobin levels. We routinely evaluate ferritin during hair-loss workups because restoring it can meaningfully improve growth in many midlife and older women.
Aging also reduces the skin’s ability to synthesize vitamin D, a hormone-like nutrient essential for follicular signaling. Low vitamin D is associated with increased telogen shedding and impaired anagen initiation. As adults spend more time indoors or protect themselves from the sun for skin cancer prevention, deficiency becomes common. Correcting vitamin D insufficiency often reduces shedding episodes regardless of age or sex.
Protein intake is another hidden concern. Many adults in their 50s and 60s reduce dietary protein, often unintentionally. Because hair is composed almost entirely of keratinized protein, insufficient amino acid availability leads to weakened hair shafts, slower growth, and greater fragility. The body prioritizes essential organs over hair when nutrients are scarce; hair is one of the first structures to show the effects.
Micronutrients such as zinc, biotin, selenium, and folate also influence hair integrity. While true biotin deficiency is rare, suboptimal levels of zinc and folate occur more commonly with age, especially in individuals with gastrointestinal issues or those taking long-term medications that impair absorption. These deficiencies rarely cause total baldness, but they undeniably compound existing alopecia by reducing scalp resilience and hair shaft quality.
Even metabolic syndromes—such as insulin resistance and type 2 diabetes—play a role. They impair microvascular flow and increase oxidative stress in the scalp. Published research in Clinical, Cosmetic and Investigational Dermatology notes strong associations between metabolic syndrome and accelerated follicular aging, particularly in men over 50.
At DiStefano, we screen for these subtle nutritional and metabolic contributors as part of a comprehensive evaluation. Many patients come to us believing their thinning is “just aging,” only to discover correctable deficiencies that, once treated, significantly improve fullness. Nutrition is never the sole cause of late-life hair loss, but it often determines how resilient the remaining follicles will be when exposed to hormonal and senescent pressures.
Age-Related Declines in Scalp Blood Flow: Insights From Dermatologic and Vascular Research
One of the most overlooked aspects of age-related hair loss is the gradual reduction in scalp microcirculation. Hair follicles are metabolically active structures that depend on a steady flow of oxygen and nutrients. With age, vascular efficiency naturally declines. In fact, dermatopathology studies led by Dr. Ralph Trueb, published in Dermatology, document a measurable loss of perifollicular vascular density in aging scalps, particularly in men with long-standing androgenetic alopecia.
This vascular decline is not merely theoretical. Clinical phototrichogram analyses performed by Dr. Ulrike Blume-Peytavi at the Charité University Hospital and published in the Journal of the American Academy of Dermatology show that reduced scalp blood flow correlates with shorter anagen duration and diminished hair shaft diameter in older adults. The follicles are alive but under-nourished; with each cycle, their growth capacity shrinks.
Systemic aging amplifies this. Cardiologists such as Dr. Michael Criqui have shown in Circulation that arterial stiffness increases steadily after midlife, reducing capillary perfusion throughout peripheral tissues—including the scalp. In our New England patient population, this is doubly relevant, because many men in their 50s and 60s also manage hypertension, dyslipidemia, or type 2 diabetes, all of which impair microvascular function.
Smoking adds another layer of damage. In a pivotal cohort study published in Archives of Dermatology, Su and Chen demonstrated that men aged 40–91 who smoked at least 20 cigarettes per day had dramatically higher incidence of moderate-to-severe androgenetic alopecia. They concluded that chronic tobacco exposure not only constricts blood vessels but may also “injure the dermal papilla through oxidative stress and DNA damage.”
At DiStefano, we integrate these findings into real-world clinical decisions. When we evaluate an older patient, we’re not only examining pattern loss—we’re assessing vascular capacity, scalp turgor, and healing potential. Age does not disqualify any patient from medical therapy or surgery, but it does influence how we structure their plan. This is why older patients often benefit from LLLT, PRP, and medical therapy simultaneously—each modality supports perfusion and counteracts age-related microvascular decline.
Environmental and Oxidative Damage: What Decades of Scientific Studies Reveal About Aging Hair
As decades pass, the scalp accumulates environmental injuries—UV radiation, oxidative stress, pollution, and chemical exposures—that gradually weaken the follicular ecosystem. Dermatologic researchers have mapped this process extensively. In a landmark paper in The Journal of Investigative Dermatology, Dr. Akemi Ito demonstrated that chronic UV exposure induces lipid peroxidation and DNA fragmentation in follicular keratinocytes, directly impairing hair shaft formation.
Oxidative stress is similarly well-characterized. Dr. Ralph Paus, a leading hair biology researcher, published work in Experimental Dermatology showing that reactive oxygen species accelerate follicular aging by damaging stem cell niches in the bulge region—the very population responsible for lifelong hair regeneration. His work suggests that environmental oxidative damage may act as a “second hit” on top of genetic miniaturization, pushing follicles into premature senescence.
Pollution also plays a quantifiable role. In Environmental Health Perspectives, Dr. Hyun-Jin Park demonstrated that exposure to airborne particulate matter (PM10 and PM2.5) suppresses the expression of hair-growth–related proteins such as β-catenin and cyclin D1. These findings explain why individuals living in urban or industrial areas often experience accelerated thinning with age. Follicles are biologically assaulted from above (UV and pollutants) and from within (oxidative stress), creating a cumulative decline in hair resilience.
Chemical and grooming practices compound this over decades. Researchers such as Dr. Sharon Wong, writing in International Journal of Trichology, describe how repeated chemical coloring, high-heat styling, and traction hairstyles cause chronic cuticle disruption, longitudinal fissuring, and eventually shaft breakage. While this is not “hair loss” in the medical sense, it creates the visible effect of thinning. Older hair shafts—naturally drier and produced by aging follicles—are uniquely vulnerable to these cosmetic stresses.
At DiStefano, we counsel patients that environmental aging is modifiable. Protective behaviors—sun avoidance, antioxidants, gentle grooming, and cessation of smoking—meaningfully slow the cumulative damage documented in these scientific papers. Age itself is not the enemy; unmitigated oxidative injury is. When we pair environmental strategies with medical and surgical restoration, patients experience not only thicker hair but also a healthier scalp environment that supports long-term follicular survival.
Age and Response to Medical Therapies: Finasteride, Minoxidil, and Topical Innovations
Age changes the biology of hair follicles, yet medical therapies remain relevant across the lifespan. At DiStefano, we rely on robust clinical evidence to calibrate expectations for each age group—because while younger follicles tend to respond more vigorously, older follicles are far from beyond help.
Finasteride (Oral DHT Blocker):
The most influential data on age and finasteride comes from Dr. David Whiting and colleagues in a controlled multicenter trial published in the European Journal of Dermatology. Their work evaluated men aged 41 to 60 with vertex hair loss and demonstrated that finasteride significantly improved hair counts, global photographic assessments, and patient satisfaction over 24 months. Importantly, Whiting’s team confirmed that the efficacy of finasteride in men over 40 was comparable to men under 40, countering the belief that “older follicles don’t respond.”
Molecular studies from Dr. George Cotsarelis at the University of Pennsylvania, published in The Journal of Clinical Investigation, illuminate why. Even in older men, miniaturized follicles retain active stem cell populations and respond positively when DHT suppression is introduced early enough. Finasteride simply prevents further androgen-driven injury, allowing follicles—regardless of chronological age—to thicken.
Minoxidil (Topical or Compounded):
Age does influence the speed of response but not the presence of response. Clinical research by Dr. Elise Olsen, published in the Journal of the American Academy of Dermatology, demonstrated that both younger and older adults experienced increases in hair weight and hair diameter with consistent minoxidil use. The key difference is timeline: younger follicles tend to produce visible changes around month 3; older follicles often require 5–6 months before clear gains emerge.
Compounded formulas provide additional benefits. Formula 82F, containing topical finasteride and minoxidil, leverages data from Dr. Jerry Shapiro (NYU), who published in Dermatologic Therapy that topical finasteride can produce follicular DHT reductions while minimizing systemic absorption—especially helpful in postmenopausal women or older men who prefer localized therapy.
For men in their 20s, these medications are frontline defenses. For men in their 50s or 60s, medical therapy becomes a stabilizer—preserving existing hair and stiffening the foundation upon which PRP or surgery may build.
Age and Biologic Therapies: PRP, LLLT, and Regenerative Approaches
Biologic therapies are uniquely valuable because they bypass hormonal pathways and directly support follicle repair—making them exceptionally relevant for older adults whose loss is partially driven by senescence rather than pure androgen sensitivity.
Platelet-Rich Plasma (PRP):
The most authoritative meta-analysis to date was conducted by Dr. Michele Li and published in Aesthetic Plastic Surgery (2024). Reviewing randomized controlled trials, her team found that PRP significantly increased terminal hair density in androgenetic alopecia—with stronger average responses in men but clinically meaningful improvements in women as well.
Why does PRP work at older ages? Because age does not eliminate platelet-derived growth factors. Studies by Dr. Jeffrey Rapaport, published in the Journal of Cosmetic Dermatology, show that PDGF, VEGF, and IGF-1 levels remain functional in older adults. What changes is the follicle’s microenvironment—often dehydrated, inflamed, and poorly perfused. PRP directly counteracts this by increasing angiogenesis (new blood vessel formation), restoring a healthier perifollicular milieu.
For men in their 20s or 30s, PRP often boosts regrowth beyond what finasteride or minoxidil alone achieve. For men in their 50s–70s, PRP frequently revitalizes thin, aging hair and supports transplanted grafts by preparing a nutrient-rich vascular bed.
Low-Level Laser Therapy (LaserCap):
The foundational research in LLLT was performed by Dr. Michael Hamblin at Harvard Medical School and published in Lasers in Surgery and Medicine. His work established that red-light wavelengths stimulate mitochondrial cytochrome c oxidase, increasing ATP production and triggering anti-inflammatory pathways. This effect is independent of age—mitochondria respond at 20 the same way they do at 70.
A randomized controlled trial by Dr. Raymond Lanzafame, published in the American Journal of Clinical Dermatology, demonstrated that both younger and older adults experienced increased hair density and shaft thickness with consistent LLLT use. The trial included patients up to age 65, showing uniform benefit across age groups.
For younger patients, LLLT is often adjunctive—enhancing active regrowth. For older patients, it becomes a foundational therapy, improving scalp perfusion and slowing senescence-driven thinning.
At DiStefano, we lean heavily on these biologic strategies for adults in their 40s–70s, because they directly address the vascular, metabolic, and inflammatory elements of aging that medications alone do not fully cover.
Hair Transplant Surgery Across Ages: What the Scientific Literature Shows About Outcomes
Hair transplantation remains the most definitive, permanent solution for age-related hair loss, but age affects planning—not eligibility. At DiStefano, we lean heavily on decades of clinical evidence and our own 30-year experience to design safe, age-appropriate surgery for every patient.
The widely cited work of Dr. Walter Unger, published in Dermatologic Surgery, demonstrates that donor dominance—the principle that transplanted follicles retain their genetic characteristics—holds true regardless of patient age. Whether a graft is moved at age 25 or age 70, it grows according to its own genetic programming, not the age of the recipient site.
More recently, Dr. Damkerng Pathomvanich, writing in Hair Transplant Forum International, documented successful growth rates in patients aged 60–79 who underwent FUE or FUT, with graft survival comparable to younger cohorts when vascular limitations were respected. His findings mirror our real-world outcomes in New England: older adults frequently achieve excellent, natural growth when the surgical plan is conservative, the donor area is harvested judiciously, and post-operative perfusion is optimized.
Age also influences healing. Research from Dr. Bessam Farjo in Annals of Plastic Surgery shows that older scalps may have slightly reduced elasticity and slower re-epithelialization, but not enough to contraindicate surgery. The key is technique. We often reduce incision density in adults over 60 to match vascular capacity and avoid substrate overload. This aligns with vascular insights from Dr. Ralph Trueb that aged perifollicular microcirculation functions best under moderate surgical demand.
Younger adults, especially men under 25, pose a different challenge. Their future pattern is unstable. Consistent with the recommendations of Dr. Nicole Rogers and Dr. Jerry Cooley in Facial Plastic Surgery Clinics of North America, we avoid prematurely lowering hairlines in very young men. Instead, we reinforce conservative patterns that will continue to look natural as the patient ages into his 40s, 50s, and beyond.
No-Shave FUE—our patients’ favorite discreet option—has strong scientific footing as well. Dr. James Harris, a pioneer in FUE, published in Dermatologic Surgery that limited-shave harvesting does not reduce graft survival when performed with precision. For older professionals or public-facing individuals, this technique provides an elegant way to restore density without advertising the procedure.
In every case, age informs strategy, not success. The science is clear: well-selected patients, regardless of decade, achieve high graft survival, natural growth, and long-term cosmetic improvement.
Timing Treatment by Decade: Evidence-Based Recommendations for Men and Women
Decades of research inform our age-specific approach at DiStefano. The goal is simple: intervene before irreversible miniaturization, and tailor the plan to the biological realities of each age group.
20s (Early-Onset Miniaturization):
Younger men often experience aggressive androgen influence. Studies from Dr. Jose María Lueangarun in International Journal of Trichology show that early intervention with finasteride dramatically slows future Norwood progression. Women in their 20s with androgen-related thinning (often tied to PCOS) respond strongly to spironolactone plus topical minoxidil, as shown in work by Dr. Valerie Randall published in Endocrine Reviews.
30s (Pattern Becoming Clear):
This decade is the “fork in the road.” Follicles have endured a decade or more of DHT exposure, but still retain strong regenerative capacity. Clinical studies from Dr. Antonella Tosti in JAAD confirm that miniaturization is highly reversible in early 30s when medical therapy is layered with biologic support such as PRP. Men in their 30s who combine finasteride + minoxidil + LLLT achieve the highest long-term retention rates in the literature.
40s (Stabilization Phase):
By midlife, the pattern is usually predictable. Research from Dr. Rodney Sinclair in The Lancet highlights that women entering perimenopause show a steep decline in hair diameter due to estrogen withdrawal. This is the ideal decade for combination therapy, nutritional correction, and early transplantation planned around stable donor availability.
50s–60s (Age-Related Compounding):
Vascular studies by Dr. Blume-Peytavi document declining perifollicular perfusion after age 55. This is why PRP and LLLT—which directly increase angiogenesis—become disproportionately valuable. Men in this age group often benefit most from transplant + biologic therapy, while women often need a dual approach targeting both menopause-related changes and senescence.
70s and Beyond:
Contrary to outdated myths, age is not a contraindication. Work by Dr. Pathomvanich and Dr. Farjo shows that transplant outcomes remain strong into the 70s when donor hair is adequate. Medical therapies still help by preserving remaining density and enhancing graft performance, though expectations must be aligned with biologic reality.
The scientific consensus is consistent across decades: the earlier you intervene, the more you preserve—but meaningful improvement remains possible at any age.
Conclusion
Age affects hair biology in profound ways—through hormonal shifts, metabolic changes, vascular decline, oxidative injury, and follicular senescence. But modern hair restoration has evolved to meet each of these challenges with precision. At DiStefano, we combine more than 30 years of clinical expertise, 16,000+ successful procedures, and the surgical leadership of Dr. Chris Heinis to design age-specific, evidence-based treatment plans that genuinely change lives.
Whether you are in your 20s and noticing early recession, in your 40s navigating midlife thinning, or in your 70s deciding it’s finally time to restore what was lost, the science supports your decision to act. Hair follicles can be preserved, revived, and redistributed at virtually every decade of life—provided the plan is tailored, medically sound, and guided by a team that understands the biology of aging.
DiStefano Hair Restoration Center can help you directly to resolve the issue. Schedule A Free Consultation.
Does age naturally cause hair loss?
What age does male pattern baldness usually start?
Is hair transplant effective for older adults?
Do age-related hormonal changes affect women’s hair?
What is the best age to start hair-loss treatment?
References
Blume-Peytavi, U., et al. (2011). Hair follicle aging in men and women. Journal of the American Academy of Dermatology.
Cotsarelis, G., & Millar, S. (2001). Towards a molecular understanding of hair loss. Journal of Clinical Investigation.
Deng, Y., Wang, M., He, Y., Liu, F., Chen, L., & Xiong, X. (2023). Cellular senescence: ageing and androgenetic alopecia. Dermatology, 239(4), 533–541.
Farjo, B., et al. (2015). Age-related outcomes in hair transplantation. Annals of Plastic Surgery.
Hamblin, M. R. (2016). Mechanisms of low-level light therapy. Lasers in Surgery and Medicine.
Ito, A., et al. (2005). UV damage and hair follicle biology. Journal of Investigative Dermatology.
Lanzafame, R. J., et al. (2013). Low-level laser therapy for hair growth. American Journal of Clinical Dermatology.
Li, M., Qu, K., Lei, Q., Chen, M., & Bian, D. (2024). PRP effectiveness in androgenic alopecia. Aesthetic Plastic Surgery.
Olsen, E. A. (2002). Topical minoxidil in long-term hair loss management. Journal of the American Academy of Dermatology.
Paus, R., et al. (2014). Oxidative stress and follicular stem cells. Experimental Dermatology.
Pathomvanich, D. (2014). Hair transplantation in the elderly. Hair Transplant Forum International.
Randall, V. A. (2008). Androgens and hair growth regulation. Endocrine Reviews.
Rapaport, J., et al. (2019). PRP for hair density improvement. Journal of Cosmetic Dermatology.
Shapiro, J. (2018). Topical finasteride pharmacodynamics. Dermatologic Therapy.
Sinclair, R., et al. (2018). Female pattern hair loss and hormonal transition. The Lancet.
Su, L. H., & Chen, T. H. (2007). Smoking and baldness relationship. Archives of Dermatology.
Tosti, A., et al. (2016). Reversibility of early miniaturization. Journal of the American Academy of Dermatology.
Trueb, R. M. (2009). Aging hair: The role of microvascular decline. Dermatology.
Unger, W. (2004). Donor dominance in hair transplantation. Dermatologic Surgery.
Wong, S. (2012). Hair shaft fragility due to cosmetic practices. International Journal of Trichology.
